Tech Company Financing Transactions

Tacurion Pharma Funding Round

Tacurion Pharma, operating out of Bridgewater, scored $15 million from Astellas Venture Capital, InterWest Partners and Sutter Hill Ventures.

Transaction Overview

Company Name
Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Bridgewater, NJ 08807
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Tacurion Pharma Inc develops and commercializes ASP7035.
Profile
Tacurion Pharma LinkedIn Company Profile
Social Media
Tacurion Pharma Company Twitter Account
Company News
Tacurion Pharma News
Facebook
Tacurion Pharma on Facebook
YouTube
Tacurion Pharma on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2013: Soltaix venture capital transaction
Next: 6/30/2013: Quote Roller venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary